Go Digit General Insurance Ltd (GODIGIT) Q1 FY27 Results Analysis: PAT Plunges 37.6%, Combined Ratio Worsens
CompoundingAI Research
Updated July 23, 2026
2 min read
Negative
Go Digit General Insurance Ltd's Q1 FY27 numbers came in soft, with revenue of Rs. 2,359.36 Cr (+8.25% YoY) and PAT growth of -37.55% YoY. Here's a quick read of what worked, what to watch, and what management said.
Quick Details| Results date | July 23, 2026 |
|---|
| Quarter | Q1 FY 2026-2027 |
|---|
| Revenue (Q1) | Rs. 2,359.36 Cr (+8.25% YoY) |
|---|
| PAT (Q1) | Rs. 86.39 Cr (-37.55% YoY) |
|---|
| EPS (Q1) | Rs. 0.93 (-38.00% YoY) |
|---|
| Market cap | Rs. 25,949.14 Cr |
|---|
| CMP | Rs. 280.85 |
|---|
Quarter Snapshot
Combined ratio deteriorated to 112.3% and PAT fell 37.55% YoY, driven by widening underwriting losses in Motor and Health Group segments. Positives include improved net retention and higher investment income, but near-term outlook remains challenging until motor corrective actions show results in Q2 FY27.
Key Investment Insights
Key Positives
- Net Premium Written grew 7.36% YoY to Rs.2,094.19 Cr, driven by improved net retention ratio (76.7% vs 65.4% YoY).
- Investment income grew 12.02% YoY to Rs.351.83 Cr, supported by higher AUM and yield.
- Solvency ratio improved to 2.43x from 2.27x YoY, well above regulatory minimum.
- Health Government segment underwriting profit rose 204.93% YoY to Rs.15.46 Cr.
- Crop segment swung to underwriting profit of Rs.5.74 Cr from a loss of Rs.0.75 Cr YoY.
Risk Factors
- Combined ratio deteriorated to 112.3% from 108.6% YoY, driven by higher claims and expense ratios.
- Underwriting loss widened 45.68% YoY to Rs.282.01 Cr, primarily from Motor segment.
- PAT fell 37.55% YoY to Rs.86.39 Cr, impacted by higher claims, expenses, and effective tax rate.
- Health Group/Corporate underwriting loss more than doubled to Rs.51.43 Cr.
- Effective tax rate rose to 25.17% from 13.90% YoY, adding to profit decline.
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now